2 Clinical Trials for Rheumatic Fever
To understand the severity and nature of participants experiences during irAEs following immune checkpoint inhibitor immunotherapy.
This is a phase 1 study of SYNCAR-001 + STK-009 in patients with severe, refractory systemic autoimmune rheumatic disease.